Everyday Health on MSN
Rheumatoid Arthritis in Men: What’s Different?
Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...
Higher physical work strain is tied to worse joint inflammation at diagnosis in patients with rheumatoid arthritis with ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
MedPage Today on MSN
Phone Data May Give Early Warning on Rheumatoid Arthritis Flares
Rheumatoid arthritis patients often don't notice disease flares until symptoms have already worsened substantially. As joint ...
A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide ...
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...
Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...
The prevalence of anti-citrullinated protein antibodies is low in patients with coronary artery disease without RA; in those with RA, C-reactive protein levels may explain the antibody-mortality link.
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
Augurex CEO Neil Klompas describes why it is difficult for biomarkers to diagnose rheumatoid arthritis in some cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results